CAS NO: | 1313730-14-1 |
包装 | 价格(元) |
10mg | 询价 |
50mg | 询价 |
Cas No. | 1313730-14-1 |
别名 | Teijin compound 1 hydrochloride |
化学名 | (S)-N-(2-((1-(4-chlorobenzyl)pyrrolidin-3-yl)amino)-2-oxoethyl)-3-(trifluoromethyl)benzamide hydrochloride |
Canonical SMILES | ClC1=CC=C(C=C1)CN2C[C@H](CC2)NC(CNC(C3=CC=CC(C(F)(F)F)=C3)=O)=O.Cl |
分子式 | C21H21ClF3N3O2.HCl |
分子量 | 476.32 |
溶解度 | DMSO: 100 mM,Water: 10 mM |
储存条件 | Store at -20℃ |
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while. |
Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
产品描述 | Teijin compound 1 is a specific CCR 2 antagonist with IC50s of 24 and 180 nM in chemotaxis and binding assay, respectively. Ile263 and Thr292 in CCR2 contribute significantly to binding of Teijin compound 1 in CCR2. Residue Glu291 in TM7, a highly conserved residue in many CC chemokine receptors, contributes substantially to binding of the protonated Teijin compound 1, and CCL2. His121 on TM3 and Ile263 on TM6 also strongly interact with Teijin compound 1[2]. In ApoE-deficient mice, Vp-TSL targets specifically aortic plaque endothelial VCAM-1 and Teijin compound 1 reduces the mouse monocyte/macrophage cell line (RAW 264.7) adhesion/ infiltration into the aorta[3]. References: |
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |